Pharma becoming more aggressive outsourcing buyer

6 July 2008

The latest industry Perspective research paper from USA-headquartered EquaTerra depicts the pharmaceutical industry as reaching a critical inflection point - either change operating models or face long-term decline. In response, EquaTerra, a business advisory firm, reports that pharmaceutical companies have been actively adopting alternative service delivery models - shared services, information technology and business process outsourcing - across general and administrative support functions. Now, however, they are poised to expand outsourcing into more strategic business activities, it adds.

As the contracting market for pharmaceuticals matures, both traditional multinational outsourcing and Indian service providers, who initially entered the market via information technology and IT outsourcing, are targeting the knowledge-intensive pharmaceutical industry with expanded business process and knowledge process outsourcing services.

Not surprisingly, says EquaTerra, these providers cite the top three business drivers for their services as:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight